Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-15,300
Closed -$1.47M 4374
2021
Q3
$1.47M Buy
15,300
+8,600
+128% +$939K ﹤0.01% 2263
2021
Q2
$715K Sell
6,700
-600
-8% -$59K ﹤0.01% 2786
2021
Q1
$654K Sell
7,300
-9,600
-57% -$1.06M ﹤0.01% 2678
2020
Q4
$1.7M Buy
16,900
+5,700
+51% +$425K ﹤0.01% 1599
2020
Q3
$547K Buy
+11,200
New +$538K ﹤0.01% 2171

Other funds holding CRNC

John Overdeck's CRNC Position: Q2 2026 in Review

John Overdeck reduced its Cerence (CRNC) stake by 30% in Q2 2026, selling an estimated $3.47M and leaving 807,773 shares worth $9.14M. The position accounts for 0.01% of the portfolio, ranked #1588.

John Overdeck first reported a position in CRNC in Q4 2019 and has held it in 22 quarters since. The position peaked at $22.7M in Q1 2022. 193 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • John Overdeck held 807,773 shares of Cerence worth $9.14M as of Q2 2026.
  • John Overdeck sold 354,015 Cerence shares in Q2 2026, an estimated $3.47M.
  • Cerence made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1588 holding.
  • John Overdeck first reported a position in Cerence in Q4 2019 and has held it in 22 quarters since.
  • John Overdeck's Cerence position peaked at $22.7M in Q1 2022.
  • 193 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.